Symposium on Air Toxics: Biomarkers in Environmental Applications

• Air Toxics: Biomarkers in Environmental Applications--Overview and Summary of Recommendations
  Andrij Holian
  p. 851

• Air Toxics Regulatory Issues Facing Urban Settings
  Kenneth Olden and Janet Guthrie
  p. 857

• Breath Measurements as Volatile Organic Compound Biomarkers
  Lance Wallace, Timothy Buckley, Edo Pellizzari, and Sydney Gordon
  p. 861

• Measurement of Volatile Organic Compounds in Human Blood
  David L. Ashley, Michael A. Bonin, Frederick L. Cardinali, Joan M. McCraw, and Joe V. Wooten
  p. 871

• Protein Adduct Biomarkers: State of the Art
  Mark J. Meyer and William E. Bechtold
  p. 879

• Human DNA Adduct Measurements: State of the Art
  Miriam C. Poirier and Ainsley Weston
  p. 883

• Identification of Needs in Biomarker Research
  Jonathan B. Ward Jr. and Rogene E. Henderson
  p. 895

• Polycyclic Aromatic Hydrocarbons (PAHs), Nitro-PAHs and Related Environmental Compounds: Biological Markers of Exposure and Effects
  Glenn Talaska, Patricia Underwood, Andrew Maier, Joellen Lewtas, Nathaniel Rothman, and Marlene Jaeger
  p. 901

• Biomonitoring of 1,3-Butadiene and Related Compounds
  Siv Osterman-Golkar and James A. Bond
  p. 907

• Monitoring Human Lymphocytic DNA-Protein Cross-links as Biomarkers of Biologically Active Doses of Chromate
  Max Costa, Anatoly Zhitkovich, Paolo Toniolo, Emanuela Taioli, Todor Popov, and Annekatrin Lukanova
  p. 917

• Utilization of Biomarker Data for Clinical and Environmental Intervention
  David C. Christiani
  p. 921

  Polycyclic Aromatic Hydrocarbon Metabolites in Urine as Biomarkers of Exposure and Effect
  Paul Strickland, Daehee Kang, and Pornchai Sithisarankul
  p. 927

Conference on Beryllium-related Diseases

• Introduction to the Conference on Beryllium-related Diseases
  C. W. Jameson
  p. 935

• The Natural History of Beryllium Sensitization and Chronic Beryllium Disease
  Lee S. Newman, Jenifer Lloyd, and Elaine Daniloff
  p. 937

• Chronic Beryllium Disease: Diagnosis and Management
  Milton D. Rossman
  p. 945

• United Kingdom Beryllium Registry: Mortality and Autopsy Study
  W. Jones Williams
  p. 949

• Significance of the Blood Beryllium Lymphocyte Proliferation Test
  Lee S. Newman
  p. 953

• Statistical Methods for the Blood Beryllium Lymphocyte Proliferation Test
  Edward L. Frome, Matthew H. Smith, L. Gayle Littlefield, Richard L. Neubert, and Shirley P. Colyer
  p. 957

• Cytokine Production by Bronchoalveolar Lavage Cells in Chronic Beryllium Disease
  Sally S. Tinkle, Patricia W. Schwitters, and Lee S. Newman
  p. 969

• Animal Models of Beryllium-induced Lung Disease
  Gregory L. Finch, Mark D. Hoover, Fletcher F. Hahn, Kristen J. Nikula, Steven A. Belinsky, Patrick J. Haley, and William C. Griffith
  p. 973

• Rocky Flats Beryllium Health Surveillance
  Arthur W. Stange, F. Joseph Furman, and Duane E. Hilmas
  p. 981

• Commentary: Medical and Ethical Issues in Genetic Screening--An Academic View
  Neil A. Holtzman
  p. 987

  Commentary: A Moral History of the Evolution of a Caste of Workers
  Sheldon Wilfred Samuels
  p. 991

The Second NIEHS Predictive-Toxicology Evaluation Experiment: 30 Chemical Carcinogenicity Bioassays

• Introduction: The NIEHS Predictive-Toxicology Evaluation Project
  Douglas W. Bristol, Joseph T. Wachsman, and Arnold Greenwell
  p. 1001

• COMPACT and Molecular Structure in Toxicity Assessment: A Prospective Evaluation of 30 Chemicals Currently Being Tested for Rodent Carcinogenicity by the NCI/NTP
  David F.V. Lewis, C. Ioannides, and D.V. Parke
  p. 1011

• A RASH Analysis of National Toxicology Program Data: Predictions for 30 Compounds to Be Tested in Rodent Carcinogenesis Experiments
  Troyce D. Jones and Clay E. Easterly
  p. 1017

• Prediction of Rodent Carcinogenicity Bioassays from Molecular Structure Using Inductive Logic Programming
  Ross D. King and Ashwin Srinivasan
  p. 1031

• Prediction of Rodent Carcinogenicity of Further 30 Chemicals Bioassayed by the U.S. National Toxicology Program
  Romualdo Benigni, Cristina Andreoli, and Romano Zito
  p. 1041

• Prediction of the Carcinogenicity of a Second Group of Organic Chemicals Undergoing Carcinogenicity Testing
  Y.P. Zhang, N. Sussman, O.T. Macina, H.S. Rosenkranz, and G. Klopman
  p. 1045

• Prediction of the Rodent Carcinogenicity of Organic Compounds from Their Chemical Structures Using the FALS Method
  Ikuo Moriguchi, Hiroyuki Hirano, and Shuichi Hirono
  p. 1051

• Carcinogenicity Predictions for a Group of 30 Chemicals Undergoing Rodent Cancer Bioassays Based on Rules Derived from Subchronic Organ Toxicities
  Yongwon Lee, Bruce G. Buchanan, and Herbert S. Rosenkranz
  p. 1059

• Prediction of Rodent Carcinogenicity Using the DEREK System for 30 Chemicals Currently Being Tested by the National Toxicology Program
  Carol A. Marchant and The DEREK Collaborative Group
  p. 1065

• Use of the Syrian Hamster Embryo Cell Transformation Assay for Carcinogenicity Prediction of Chemicals Currently Being Tested by the National Toxicology Program in Rodent Bioassays
  Gary A. Kerckaert, Roger Brauninger, Robert A. LeBoeuf, and Robert J. Isfort
  p. 1075

• A Mechanism-mediated Model for Carcinogenicity: Model Content and Prediction of the Outcome of Rodent Carcinogenicity Bioassays Currently Being Conducted on 25 Organic Chemicals
  Rich Purdy
  p. 1085

• Predictions for the Outcome of Rodent Carcinogenicity Bioassays: Identification of Trans-species Carcinogens and Noncarcinogens
  Raymond W. Tennant and Judson Spalding
  p. 1095

• Prediction of Rodent Carcinogenicity for 30 Chemicals
  J. Ashby
  p. 1101

  Multicomponent Criteria for Predicting Carcinogenicity: Dataset of 30 NTP Chemicals
  James Huff, Elizabeth Weisburger, and Victor A. Fung
  p. 1105